This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Instituto de Biología y Medicina Experimental | |
|---|---|
| Name | Instituto de Biología y Medicina Experimental |
| Established | 1944 |
| Type | Investigación |
| City | Buenos Aires |
| Country | Argentina |
Instituto de Biología y Medicina Experimental is a biomedical research institution founded in Buenos Aires with a history of contributions to physiology, immunology, and molecular biology. The institute has interacted with national and international entities such as Universidad de Buenos Aires, CONICET, Ministerio de Salud de la Nación (Argentina), Fundación Instituto Leloir, and Instituto Nacional de Tecnología Agropecuaria while engaging with scholars connected to Córdoba (Argentina), La Plata, Hospital de Clínicas Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, and Instituto Malbrán.
The institute was founded amid mid‑20th century scientific developments involving figures linked to Bernardo Houssay, Luis F. Leloir, César Milstein, Héctor Pérez, and institutions such as Universidad de Buenos Aires, CONICET, Fundación Instituto Leloir, Instituto Malbrán, and Hospital de Clínicas Buenos Aires; its early years paralleled events like the Perónism era and collaborations with laboratories in La Plata and Córdoba (Argentina). During the 1960s and 1970s the institute expanded its laboratories and networks with groups associated with Leloir Institute, Instituto Pasteur, Harvard University, Massachusetts Institute of Technology, and National Institutes of Health, while navigating national policies tied to Consejo Nacional de Investigaciones Científicas y Técnicas and links to clinics such as Hospital Garrahan. In the late 20th century the institute's trajectory intersected with international programs connected to World Health Organization, Pan American Health Organization, European Molecular Biology Organization, Max Planck Society, and collaborations with researchers trained at University of Cambridge and University of Oxford.
The institute's mission aligns with mandates promoted by CONICET, Universidad de Buenos Aires, Ministerio de Ciencia, Tecnología e Innovación (Argentina), FUNCEI, and international frameworks like UNESCO and World Health Organization to advance biomedical knowledge, foster translational research, and support public health initiatives. Objectives emphasize producing peer‑reviewed output suitable for venues such as Nature, Science (journal), Cell (journal), Proceedings of the National Academy of Sciences, and regional journals linked to Asociación Argentina de Bioquímica Clínica and Revista Argentina de Microbiología. The institute seeks to train researchers who can work in environments connected to Hospital de Clínicas Buenos Aires, Hospital de Niños Ricardo Gutiérrez, Instituto Malbrán, and international centers including Johns Hopkins University, Karolinska Institutet, Imperial College London.
Governance is modeled on academic and research institutions such as Universidad de Buenos Aires, CONICET, Fundación Instituto Leloir, and Instituto Leloir, with a directorate, scientific council, administrative units, and technical cores analogous to structures at Instituto Pasteur, Ludwig Institute for Cancer Research, Max Planck Institute, Salk Institute, and Cold Spring Harbor Laboratory. Departments typically mirror disciplines represented at Harvard Medical School, Mayo Clinic, Mount Sinai Hospital (New York), Instituto Malbrán, and Hospital de Clínicas Buenos Aires, facilitating interactions with units named after figures like Bernardo Houssay and Luis F. Leloir. Management practices incorporate grant offices and technology transfer cells that coordinate with Agencia I+D+i, CONICET, Universidad de Buenos Aires, Fundación Bunge y Born, and regional partners in São Paulo (state), Santiago (Chile), and Montevideo.
Research lines reflect themes found in institutions such as Instituto Leloir, Instituto Malbrán, Harvard Medical School, Massachusetts Institute of Technology, Karolinska Institutet, and Max Planck Society and include molecular biology, immunology, physiology, neurobiology, and infectious disease. Active programs address questions relevant to World Health Organization priorities and regional health issues studied at Hospital Garrahan, Hospital de Clínicas Buenos Aires, Instituto Malbrán, ANLIS Malbrán, and Ministerio de Salud de la Nación (Argentina); projects have interfaced with international consortia from European Molecular Biology Laboratory, NIH, Wellcome Trust, and Bill & Melinda Gates Foundation. Investigations have produced work comparable to studies published in Nature Medicine, Lancet, Journal of Experimental Medicine, Cell, and PNAS, involving techniques parallel to those used at Salk Institute, Cold Spring Harbor Laboratory, Whitehead Institute, and Broad Institute.
The institute provides postgraduate training integrated with Universidad de Buenos Aires, CONICET doctoral programs, and exchange schemes with universities such as University of Cambridge, University of Oxford, Harvard University, Massachusetts Institute of Technology, and Karolinska Institutet. It supervises theses and hosts workshops similar to programs at Instituto Leloir, Instituto Malbrán, Fundación Instituto Leloir, Harvard Medical School, and Imperial College London, and contributes faculty to courses at Facultad de Medicina (UBA), Facultad de Ciencias Exactas y Naturales (UBA), Hospital de Clínicas Buenos Aires, and regional training centers in Santiago (Chile) and São Paulo (state).
The institute maintains formal and informal links with national and international partners including CONICET, Universidad de Buenos Aires, Fundación Instituto Leloir, Instituto Malbrán, Hospital de Clínicas Buenos Aires, World Health Organization, Pan American Health Organization, European Molecular Biology Organization, Max Planck Society, National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, Johns Hopkins University, Harvard University, Massachusetts Institute of Technology, Karolinska Institutet, Imperial College London, Ludwig Institute for Cancer Research, and regional centers in Montevideo, Santiago (Chile), and São Paulo (state). Collaborative outputs include joint projects, co‑supervised theses, multicenter studies, and technology transfer agreements modeled after partnerships seen between Instituto Pasteur and universities like University of Cambridge.
Facilities encompass wet labs, cell culture suites, microscopy cores, genomics platforms, proteomics units, and biosafety laboratories similar to those at Instituto Leloir, Instituto Malbrán, Salk Institute, Broad Institute, Cold Spring Harbor Laboratory, and Whitehead Institute. Equipment and platforms support workflows used in collaborations with CONICET, Universidad de Buenos Aires, Fundación Instituto Leloir, European Molecular Biology Laboratory, National Institutes of Health, and Max Planck Society, enabling studies that interface with clinical sites such as Hospital Garrahan and Hospital de Clínicas Buenos Aires. The institute's infrastructure strategy mirrors practices at major centers including Harvard Medical School, Johns Hopkins University, Karolinska Institutet, and Imperial College London in maintaining cores for high‑throughput sequencing, mass spectrometry, advanced imaging, and animal facilities.